Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. [electronic resource]
Producer: 20200831Description: 3 p. digitalISSN:- 1475-2840
- Aged
- Aspirin -- adverse effects
- Biomarkers -- blood
- Blood Coagulation -- drug effects
- Clopidogrel -- adverse effects
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Female
- Fibrin -- metabolism
- Humans
- Male
- MicroRNAs -- blood
- Middle Aged
- P-Selectin -- blood
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Prasugrel Hydrochloride -- adverse effects
- Primary Prevention
- Secondary Prevention
- Thrombosis -- blood
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.